Glenview State Bank Trust Department’s Gilead Sciences GILD Stock Holding History

Glenview State Bank Trust Department’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$874K	Hold	12,694	–	–	0.27%	63
2021 Q1	$820K	Buy	12,694 +34	+0.3%	+$2.19K	0.27%	62
2020 Q4	$737K	Buy	12,660 +185	+1%	+$11.2K	0.26%	64
2020 Q3	$788K	Sell	12,475 -2,375	-16%	-$165K	0.3%	56
2020 Q2	$1.14M	Sell	14,850 -100	-0.7%	-$7.66K	0.47%	40
2020 Q1	$1.12M	Sell	14,950 -500	-3%	-$34.5K	0.54%	39
2019 Q4	$1M	Sell	15,450 -800	-5%	-$52.1K	0.39%	48
2019 Q3	$1.03M	Sell	16,250 -323	-2%	-$21.1K	0.42%	47
2019 Q2	$1.12M	Sell	16,573 -300	-2%	-$19.7K	0.46%	40
2019 Q1	$1.1M	Sell	16,873 -150	-0.9%	-$9.97K	0.47%	42
2018 Q4	$1.06M	Sell	17,023 -1,600	-9%	-$112K	0.51%	38
2018 Q3	$1.44M	Sell	18,623 -1,000	-5%	-$75.5K	0.63%	37
2018 Q2	$1.39M	Sell	19,623 -1,150	-6%	-$81.2K	0.64%	36
2018 Q1	$1.57M	Sell	20,773 -2,686	-11%	-$214K	0.74%	32
2017 Q4	$1.68M	Sell	23,459 -1,350	-5%	-$103K	0.77%	31
2017 Q3	$2.01M	Sell	24,809 -300	-1%	-$22.9K	0.98%	33
2017 Q2	$1.78M	Sell	25,109 -1,800	-7%	-$120K	0.91%	33
2017 Q1	$1.83M	Sell	26,909 -500	-2%	-$35.2K	0.95%	32
2016 Q4	$1.96M	Buy	27,409 +455	+2%	+$33.8K	1.07%	31
2016 Q3	$2.13M	Buy	26,954 +2,336	+9%	+$190K	1.2%	30
2016 Q2	$2.05M	Buy	24,618 +5,395	+28%	+$479K	1.19%	30
2016 Q1	$1.76M	Buy	19,223 +1,000	+5%	+$90.2K	1.07%	31
2015 Q4	$1.84M	Buy	18,223 +4,450	+32%	+$463K	1.14%	31
2015 Q3	$1.35M	Buy	13,773 +3,000	+28%	+$333K	0.91%	32
2015 Q2	$1.26M	Sell	10,773 -450	-4%	-$49.2K	0.77%	36
2015 Q1	$1.1M	Buy	11,223 +2,100	+23%	+$213K	0.66%	40
2014 Q4	$860K	Buy	9,123 +1,950	+27%	+$202K	0.52%	43
2014 Q3	$764K	Buy	7,173 +200	+3%	+$19.6K	0.47%	46
2014 Q2	$578K	Buy	6,973 +1,350	+24%	+$105K	0.35%	51
2014 Q1	$398K	Buy	5,623 +873	+18%	+$68.5K	0.25%	58
2013 Q4	$357K	Buy	+4,750	New	+$331K	0.22%	62

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Glenview State Bank Trust Department's GILD Position: Q2 2021 in Review

Glenview State Bank Trust Department held its Gilead Sciences (GILD) position steady in Q2 2021 at 12,694 shares worth $874K. The position accounts for 0.27% of the portfolio, ranked #63.

Glenview State Bank Trust Department first reported a position in GILD in Q4 2013 and has held it in 31 quarters since. The position peaked at $2.13M in Q3 2016. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

Glenview State Bank Trust Department held 12,694 shares of Gilead Sciences worth $874K as of Q2 2021.
Glenview State Bank Trust Department left its Gilead Sciences share count unchanged in Q2 2021.
Gilead Sciences made up 0.27% of Glenview State Bank Trust Department's portfolio in Q2 2021, its #63 holding.
Glenview State Bank Trust Department first reported a position in Gilead Sciences in Q4 2013 and has held it in 31 quarters since.
Glenview State Bank Trust Department's Gilead Sciences position peaked at $2.13M in Q3 2016.
1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Glenview State Bank Trust Department's 13F filing for Q2 2021, filed 28 Jul 2021.